Hemophagocytic lymphohistiocytosis presenting as acute coronary syndrome

Authors

  • Gabriel Melki St. Joseph’s University Medical Center, Internal Medicine Department, Paterson, NJ, USA https://orcid.org/0000-0003-0381-1880
  • Mina Fransawy Alkomos St. Joseph’s University Medical Center, Internal Medicine Department, Paterson, NJ, USA https://orcid.org/0000-0002-7669-1173
  • Sushant Nanavati St. Joseph’s University Medical Center, Pulmonary and Critical Care Department, Paterson, NJ, USA https://orcid.org/0000-0002-5452-2483
  • Vinod Kumar St. Joseph’s University Medical Center, Hematology and Oncology Department, Paterson, NJ, USA
  • Christina Mariyam St. Joseph’s University Medical Center, Internal Medicine Department, Paterson, NJ, USA https://orcid.org/0000-0003-3210-4317
  • Michael Maroules St. Joseph’s University Medical Center, Hematology and Oncology Department, Paterson, NJ, USA

DOI:

https://doi.org/10.4322/acr.2021.285

Keywords:

Lymphohistiocytosis, Hemophagocytic, Acute Coronary Syndrome, Glucose 6 Phosphate Dehydrogenase Deficiency

Abstract

Acquired Hemophagocytic Lymphohistiocytosis is a rare and deadly syndrome resulting from an overactive immune system, with uncontrolled activation of macrophages and lymphocytes, hypercytokinemia, and systemic inflammatory response. A 75-year-old male presented with typical anginal pain and was diagnosed with the acute coronary syndrome, which required a percutaneous transluminal coronary angioplasty. Instead of resolving the symptoms, the patient began to exhibit pyrexia and worsening altered sensorium with progressing renal failure, anemia, thrombocytopenia and respiratory failure. This constellation of symptoms caused the patient to require mechanical ventilation and hemodialysis. Upon laboratory analysis, hyperferritinemia provided an indication to the diagnosis of acquired hemophagocytic lymphohistiocytosis. After the initiation of dexamethasone, the patient made a significant recovery and was discharged from the hospital.

Downloads

Download data is not yet available.

References

Janka G, Lehmberg K. Hemophagocytic lymphohistiocytosis: pathogenesis and treatment. Hematology (Am Soc Hematol Educ Program). 2013;2013(1):605-11. http://dx.doi.org/10.1182/asheducation-2013.1.605. PMid:24319239.

Farquhar JW, Claireaux AE. Familial haemophagocytic reticulosis. Arch Dis Child. 1952;27(136):519-25. http://dx.doi.org/10.1136/adc.27.136.519. PMid:13008468.

Rosado FG, Kim AS. Hemophagocytic lymphohistiocytosis: an update on diagnosis and pathogenesis. Am J Clin Pathol. 2013;139(6):713-27. http://dx.doi.org/10.1309/AJCP4ZDKJ4ICOUAT. PMid:23690113.

Morimoto A, Nakazawa Y, Ishii E. Hemophagocytic lymphohistiocytosis: Pathogenesis, diagnosis, and management. Pediatr Int (Roma). 2016;58(9):817-25. http://dx.doi.org/10.1111/ped.13064. PMid:27289085.

George MR. Hemophagocytic lymphohistiocytosis: review of etiologies and management. J Blood Med. 2014;5:69-86. http://dx.doi.org/10.2147/JBM.S46255. PMid:24966707.

Parikh SA, Kapoor P, Letendre L, Kumar S, Wolanskyj AP. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis. Mayo Clin Proc. 2014;89(4):484-92. http://dx.doi.org/10.1016/j.mayocp.2013.12.012. PMid:24581757.

Rivière S, Galicier L, Coppo P, et al. Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients. Am J Med. 2014;127(11):1118-25. http://dx.doi.org/10.1016/j.amjmed.2014.04.034. PMid:24835040.

Campos FPF, Lima PP, Lima FR, et al. Hemophagocytic lymphohistiocytosis of indeterminate cause: a fatal adult case. Autops Case Rep. 2012;2(2):11-20. http://dx.doi.org/10.4322/acr.2012.011. PMid:31528566.

Henter JI, Horne A, Arico M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124-31. http://dx.doi.org/10.1002/pbc.21039. PMid:16937360.

Barbuto JA. Hemophagocytic lymphohistiocytosis: a rare diagnosis, an even rarer opportunity to appraise our understanding of the immune system. Autops Case Rep. 2015;5(1):1-5. http://dx.doi.org/10.4322/acr.2014.042. PMid:26484317.

Wang X, Zhang S, Li L, et al. Ticagrelor-induced thrombotic thrombocytopenic purpura: a case report and review of the literature. Medicine. 2018;97(26):e11206. http://dx.doi.org/10.1097/MD.0000000000011206. PMid:29952973.

Downloads

Published

2021-08-26

Issue

Section

Clinical Case Report

How to Cite

Melki, G. ., Fransawy Alkomos, M. ., Nanavati, . S. ., Kumar, V. ., Mariyam, C. ., & Maroules, M. . (2021). Hemophagocytic lymphohistiocytosis presenting as acute coronary syndrome. Autopsy and Case Reports, 11, e2021285. https://doi.org/10.4322/acr.2021.285